ARTICLE | Clinical News
Hepatitis B DNA vaccine: Began Phase I trial
March 5, 2001 8:00 AM UTC
Powderject Pharmaceuticals plc (LSE:PJP), Oxford, U.K. Product: Hepatitis B DNA vaccine Business: Infectious diseases Therapeutic category: Vaccine Target: Immune cells Description: DNA vaccine agains...